These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15311891)

  • 1. [Therapy of break-through pain].
    Krankenpfl J; 2004; 42(3-4):89. PubMed ID: 15311891
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakthrough pain with the fentanyl patch.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Dec; 97(12):18-20. PubMed ID: 9413326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic pain--new patch size expands therapy spectrum].
    MMW Fortschr Med; 2004 Dec; 146(49):56-7. PubMed ID: 15646722
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guidelines.
    Aronoff GM; Brennan MJ; Pritchard DD; Ginsberg B
    Pain Med; 2005; 6(4):305-14. PubMed ID: 16083461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective pain therapy with good tolerability. New opioid administration form by transdermal patch].
    MMW Fortschr Med; 2005 Nov; 147(46):66-7. PubMed ID: 16358643
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fentanyl patch in the treatment of severe chronic pain].
    Nolte T
    MMW Fortschr Med; 2009 Oct; 151(40):45. PubMed ID: 19927919
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing breakthrough pain with OTFC.
    Pasero C; McCaffery M
    Am J Nurs; 1999 Apr; 99(4):20. PubMed ID: 10234316
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal fentanyl for acute pain: techniques to enhance efficacy.
    Wolfe T
    Ann Emerg Med; 2007 May; 49(5):721-2. PubMed ID: 17452275
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
    Gordon DB
    Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intranasal delivery of systemic drugs: a new route for opioid drugs].
    Devillier P; Grassin-Delyle S; Naline E; Buenestado A; Blouquit-Laye S; Advenier C
    Therapie; 2010; 65(5):475-81. PubMed ID: 21144483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
    Prescrire Int; 2009 Oct; 18(103):205. PubMed ID: 19882786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pain: etiology and drug treatment].
    Kochs E
    Krankenpfl J; 2005; 43(7-10):198-9. PubMed ID: 16515270
    [No Abstract]   [Full Text] [Related]  

  • 16. [Paradigm change in therapy of moderate chronic opioid responsive pain. Fentanyl alternative to weak opioids].
    Riem L
    MMW Fortschr Med; 2004 Dec; 146(49):57. PubMed ID: 15646723
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trials: early use of transdermal opioid therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):64-5. PubMed ID: 15906440
    [No Abstract]   [Full Text] [Related]  

  • 18. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral oxymorphone (Opana).
    Med Lett Drugs Ther; 2007 Jan; 49(1251):3-4. PubMed ID: 17179898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.